Caldwell Sutter Capital, Inc. Bridge Bio Pharma, Inc. Transaction History
Caldwell Sutter Capital, Inc.
- $215 Billion
- Q3 2024
A detailed history of Caldwell Sutter Capital, Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Caldwell Sutter Capital, Inc. holds 2,200 shares of BBIO stock, worth $58,278. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,200
Previous 2,200
-0.0%
Holding current value
$58,278
Previous $55.7 Million
0.51%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
290Shares Held
170MCall Options Held
10.4MPut Options Held
2.37M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$669 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$665 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$376 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$330 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$161 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.93B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...